Solvias

Did you know that Solvias' renowned analytical expertise is also available for peptides? With over 20 peptide projects under our belt, we leverage our extensive experience and state-of-the-art technology to ensure your development stays on schedule and within budget. Learn more about our comprehensive services for peptides on our dedicated page: 🔗 Check it out: https://lnkd.in/eSze2-8p #Solvias #PeptideTesting #PharmaceuticalResearch #AnalyticalExcellence #QualityControl

Eric Manning and Christopher McGee are representing Solvias at the 11th Bio-Process Systems Alliance (BPSA) International Single-Use Summit in Washington, DC! This premier event is a hub for global industry leaders to discuss and explore key technical initiatives in single-use biopharmaceutical manufacturing. From systems integrity and automation to sustainability challenges, Eric and Chris are at the forefront of these critical conversations. Feel free to reach out to them directly to connect! #BPSASummit #bpsasummit24 #Biopharma #SingleUseTechnologies

Manufacturing Chemist has featured our white paper "Understanding and Implementing USP for Single-Use Systems" in their newsletter, which is highly relevant to the industry. Check it out: https://lnkd.in/e-iudA6y USP provides crucial guidance on the analytical testing of single-use systems (SUS) to mitigate risks associated with extractables and leachables (E&L). With the deadline fast approaching, it's essential for drug developers to start preparing now. Download our white paper with comprehensive insights on USP compliance. Get expert insights, detailed risk assessments, and practical steps for seamless compliance. #USP665 #Compliance #ManufacturingChemist #SingleUseSystems #Extractables #Leachables

We are pleased to announce our participation at the American Association of Pharmaceutical Scientists (AAPS) | @aapscomms Summer Scientific Forum in Kansas City, MO, from July 22-25! Join us at table number 11 to meet Patrick Tylek and explore how Solvias can support your pharmaceutical analysis needs. See you! #AAPS2024 #Pharma #pharmaanalysis #pharmaceuticalanalysis

We recently concluded two sales meetings, one in Utrecht, the Netherlands, and the other in RTP, US, marking a significant milestone as we prepare to open our 6th Center of Excellence. It was a wonderful opportunity to see everyone in person, engage in vital discussions, share insights, and learn from our esteemed colleagues. The tour of our new 50,000-square-foot facility in RTP was particularly inspiring. Seeing this state-of-the-art hub for cell and gene therapies in North America come to life was truly exciting. A big thank you to all who participated and made these events memorable. Exciting times ahead for Solvias! #rtp #celltherapies #genetherapies #commercialsuccess #analyticalservices #cro #cdmo #pharma

We’re proud to announce that Maria Anna Schwarz, our Principal Scientist for ATMPs, will be sharing her expertise in this upcoming series on RNA/DNA-based drugs. Don’t miss out on this exceptional opportunity to expand your knowledge and network with top professionals. Register now to secure your spot! #regulatoryaffairs #cmc #qualityassurance #rna #dna #drugdevelopment #pharma

Missed our recent webinars? We got you covered! In case you couldn't join us live, we're excited to announce that both of our recent webinars are now available on demand! 💻 Strategies for Determining Critical Quality Attributes of Nucleic Acid Therapeutics and Their Carriers 🔗 https://lnkd.in/e9fUHbZs 💻 De-risking and Accelerating Small Molecule Development, from Whiteboard to First-in-Human 🔗 https://lnkd.in/edvuDS4s Don’t miss these valuable opportunities to gain expert knowledge and stay ahead in the field. Watch them at your convenience and share with your network! #Solvias #Webinar #SmallMoleculeDevelopment #Pharmaceuticals #Biotechnology

☂ We are delighted to announce that Cergentis is now officially under the Solvias brand umbrella, as Solvias NL! This rebranding reaffirms our commitment to quality, safety, and innovation in biologics and cell and gene therapies. Solvias NL will continue to provide the high-quality data and customer service you know and trust, now with enhanced capabilities and a unified brand identity. We are excited about the possibilities that lie ahead and are fully committed to contributing to the global success of our customers. Learn more: https://lnkd.in/eJmRUnuR #Cergentis #Solvias #analyticalservices #CGT #genetherapies

Did you know that compliance with USP <665> is expected by 2026? This chapter provides crucial guidance on the analytical testing of single-use systems (SUS) to mitigate risks associated with extractables and leachables (E&L). With the deadline fast approaching, it's essential for drug developers to start preparing now. Download our white paper with comprehensive insights on USP <665> compliance. Get expert insights, detailed risk assessments, and practical steps for seamless compliance. Unlock the full document: https://lnkd.in/efB9nPUD

Join us at the PDA - Parenteral Drug Association Virus Conference in Amsterdam starting tomorrow! We’re excited to present our poster titled “Risk Mitigation of Usutu Virus Contamination in Raw Materials and Cell Lines for Biopharmaceutical Products Using Classical In Vitro Adventitious Virus Assay”. 🤝 Our team members Arnoud Boot, PhD, Melanie Schmiedl, Florian W., and Donna McMutrie are eager to discuss viral safety strategies for pharmaceutical products. Meet them at our poster or contact them directly to schedule a meeting. #PDAVirusConference #Biosafety #VirusSafety #ICHQ5A